Table 3.
Independent risk factors of tumor size and tumor stages in multivariate analysis.
| Clinicopathological features | Subtype | Factor | P value | HR | 95% CI | |
|---|---|---|---|---|---|---|
| Lower | Upper | |||||
| Tumor size >5cm | GC-NENM | TG | 0.014 | 0.499 | 0.287 | 0.867 |
| HDL-C | <0.001 | 0.493 | 0.348 | 0.699 | ||
| GC-NEC | HDL-C | 0.042 | 0.666 | 0.450 | 0.986 | |
| Advanced stages (pT>1) | GC-NENM | Size | <0.001 | 2.067 | 1.632 | 2.619 |
| TG | 0.023 | 0.399 | 0.181 | 0.879 | ||
| GC-NEC | Size | <0.001 | 2.189 | 1.660 | 2.886 | |
| Late stages (stage III+IV) | GC-NENM | Age | 0.001 | 0.969 | 0.951 | 0.987 |
| Size | <0.001 | 1.406 | 1.173 | 1.685 | ||
| TG | 0.002 | 0.279 | 0.124 | 0.628 | ||
| HDL-C | 0.001 | 0.363 | 0.203 | 0.648 | ||
| LDL-C | 0.002 | 1.899 | 1.274 | 2.830 | ||
| GC-NEC | BMI | 0.020 | 0.946 | 0.903 | 0.991 | |
| Size | <0.001 | 1.565 | 1.240 | 1.977 | ||
GC-NENM: gastric cancer expressing neuroendocrine markers but no neuroendocrine morphology; GC-NEC: mixed carcinoma with adenocarcinoma and neuroendocrine components; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; BMI: body mass index; HR: hazard ratio; CI: confidential interval.